A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 3231
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ADCC
Long Form : antibody-dependent cellular cytotoxicity
No. Year Title Co-occurring Abbreviation
2020 A bivalent, spherical virus-like particle vaccine enhances breadth of immune responses against pathogenic Ebola viruses in rhesus macaques. EBOV, GPs, MVA, SUDV, VLP
2020 A MUC16 IgG Binding Activity Selects for a Restricted Subset of IgG Enriched for Certain Simian Immunodeficiency Virus Epitope Specificities. HIV, MUC16
2020 Affinity-matured 'aquaporumab' anti-aquaporin-4 antibody for therapy of seropositive neuromyelitis optica spectrum disorders. AQP4, CDC
2020 An autoantibody against a 48-Kd fragment of human DNA-topoiomerase I in breast cancer: Implication for diagnosis and prognosis, and antibody-dependent cellular cytotoxicity in vitro. BC, NK, PBMCs, TAA
2020 Antibody-dependent cell-mediated cytotoxicity antibody responses to inactivated and live-attenuated influenza vaccination in children during 2014-15. MFR, SW13, TX12
2020 Boosting with AIDSVAX B/E Enhances Env Constant Region 1 and 2 Antibody-Dependent Cellular Cytotoxicity Breadth and Potency. mAbs, nnAbs
2020 Characterization of IgG1 Fc Deamidation at Asparagine 325 and Its Impact on Antibody-dependent Cell-mediated Cytotoxicity and FcgammaRIIIa Binding. Fc, Ig
2020 Conservation of a Neutralization Epitope of Human T-cell Leukemia Virus Type 1 (HTLV-1) among Currently Endemic Clinical Isolates in Okinawa, Japan. HTLV-1
2020 Controversy in the Use of CD38 Antibody for Treatment of Myeloma: Is High CD38 Expression Good or Bad? ADCP, CDC
10  2020 Cord blood stem cell derived CD16+ NK cells eradicated acute lymphoblastic leukemia cells using with anti-CD47 antibody. ALL, NK
11  2020 Diagnostic value of laboratory monitoring to predict severe hemolytic disease of the fetus and newborn in non-D and non-K-alloimmunized pregnancies. HDFN, PPV, RBC
12  2020 Diversity and function of maternal HIV-1-specific antibodies at the time of vertical transmission. nAbs
13  2020 Fc functional antibody responses to adjuvanted versus unadjuvanted seasonal influenza vaccination in community-dwelling older adults. HAI, QIV, TIV
14  2020 FcgammaRIIIa chromatography to enrich a-fucosylated glycoforms and assess the potency of glycoengineered therapeutic antibodies. CDC
15  2020 Flow cytometry-based assessment of direct-targeting anti-cancer antibody immune effector functions. ADCP, CDC
16  2020 Higher Baseline ADCC Responses in Chronic Nonprogressive HIV Infection Are Associated with Reduced HIV Burden in Later Course of Disease. ---
17  2020 Identification of anti-CD16a single domain antibodies and their application in bispecific antibodies. NK
18  2020 In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumab. CRC, ECCs, EGFR, KRAS, NK, TNBC
19  2020 Invitro and invivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma. ADC, IHC, SG, Trop-2, USC
20  2020 Measuring influenza hemagglutinin (HA) stem-specific antibody-dependent cellular cytotoxicity (ADCC) in human sera using novel stabilized stem nanoparticle probes. bNAb, HA, NP, SS
21  2020 Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma. ADCP, CDC, DARA, MM
22  2020 Monoclonal Antibodies with Neutralizing Activity and Fc-Effector Functions against the Machupo Virus Glycoprotein. BHF, GPC, mAbs, MACV
23  2020 Murine Model of Maternal Immunization Demonstrates Protective Role for Antibodies That Mediate Antibody-Dependent Cellular Cytotoxicity in Protecting Neonates From Herpes Simplex Virus Type 1 and Type 2. Abs, HSV
24  2020 Natural Killer Cells: Diverse Functions in Tumor Immunity and Defects in Pre-neoplastic and Neoplastic Stages of Tumorigenesis. CAR, IFN, NK, TNF
25  2020 New anti-IL-7Ralpha monoclonal antibodies show efficacy against T cell acute lymphoblastic leukemia in pre-clinical models. IL-7, mAbs, PDX, T-ALL
26  2020 PD-1 Expression on NK Cells in Malaria-Exposed Individuals Is Associated with Diminished Natural Cytotoxicity and Enhanced Antibody-Dependent Cellular Cytotoxicity. IL-6, NK
27  2020 Pluripotent stem cell-derived NK cells with high-affinity noncleavable CD16a mediate improved antitumor activity. hnCD16, iPSCs, mAbs, NK, PB-NK
28  2020 Site-specific N-glycan Analysis of Antibody-binding Fc gamma Receptors from Primary Human Monocytes. mAbs
29  2020 STIM1 knock-down decreases the affinity of obinutuzumab for CD20 by altering CD20 localization to Triton-soluble membrane. DCD
30  2020 The CD38low natural killer cell line KHYG1 transiently expressing CD16F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide. MM, MoAb, NK
31  2020 The Contribution of IgG Glycosylation to Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Complement-Dependent Cytotoxicity (CDC) in Hashimoto's Thyroiditis: An in Vitro Model of Thyroid Autoimmunity. CDC, HT, PBMCs, SA
32  2020 Thermostability detection and optimization of glycoengineered antibodies and antibody-drug conjugates based on differential scanning flouremitry analysis. ADCs, DSF, mAbs
33  2020 Tissue factor as a new target for CAR-NK cell immunotherapy of triple-negative breast cancer. CAR, TF, TF-CAR-NK, TNBC
34  2019 3D bioprinting of hepatoma cells and application with microfluidics for pharmacodynamic test of Metuzumab. ---
35  2019 A Bispecific Antibody-Based Approach for Targeting Mesothelin in Triple Negative Breast Cancer. PBMC, TNBC
36  2019 A Cetuximab-Mediated Suicide System in Chimeric Antigen Receptor-Modified Hematopoietic Stem Cells for Cancer Therapy. CAR, ddPCR, EGFRt, HSC, PET
37  2019 A high absolute lymphocyte count predicts a poor prognosis in HER-2- positive breast cancer patients treated with trastuzumab. ALC, ANC, DFS, HER2, NLR, OS
38  2019 A Mechanism of Resistance to Antibody-Targeted Immune Attack. ---
39  2019 A New Family of Small-Molecule CD4-Mimetic Compounds Contacts Highly Conserved Aspartic Acid 368 of HIV-1 gp120 and Mediates Antibody-Dependent Cellular Cytotoxicity. CD4mc, Env, nnAbs
40  2019 A novel method for determining antibody-dependent cellular phagocytosis. ADCP, CDC, FcgammaRs, MOA
41  2019 A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell Carcinoma. MDSC, NK, PFS
42  2019 A potential role of TLR2 in xenograft rejection of porcine iliac endothelial cells: An in vitro study. PIECs, TLR2
43  2019 A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein Is Dependent upon Antibody-Mediated Cellular Cytotoxicity for Protection against Marburg Virus Disease in a Murine Model. EBOV, GLA, GPs, ma-MARV, MARV
44  2019 A Tridimensional Model for NK Cell-Mediated ADCC of Follicular Lymphoma. FL, NHL
45  2019 AGI-134: a fully synthetic alpha-Gal glycolipid that converts tumors into in situ autologous vaccines, induces anti-tumor immunity and is synergistic with an anti-PD-1 antibody in mouse melanoma models. anti-PD-1, APCs, CDC
46  2019 AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice. mAK002, PSA
47  2019 An Asymmetric Opening of HIV-1 Envelope Mediates Antibody-Dependent Cellular Cytotoxicity. CD4mc, Env
48  2019 An atomistic perspective on ADCC quenching by core-fucosylation of IgG1 Fc N-glycans from enhanced sampling molecular dynamics. FcgammaRs, IgG, REMD
49  2019 An Fc-Optimized CD133 Antibody for Induction of Natural Killer Cell Reactivity against Colorectal Cancer. CRC, mAbs, NK
50  2019 An IgG1-like bispecific antibody targeting CD52 and CD20 for the treatment of B-cell malignancies. ATZ, B-NHL, biAb, CDC, CLL, mAb, RTX
51  2019 An IL-15 Superagonist, ALT-803, Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Elicited by the Monoclonal Antibody NEO-201 Against Human Carcinoma Cells. mAb, NK
52  2019 An In Vitro System for Evaluating Molecular Targeted Drugs Using Lung Patient-Derived Tumor Organoids. HER2, PDOs
53  2019 Analysis of the vaccine-induced influenza B virus hemagglutinin-specific antibody dependent cellular cytotoxicity response. IAV, IBV
54  2019 Anti-CD105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-GD2 Antibody Immunotherapy of Neuroblastoma with Activated Natural Killer Cells. A-NK, TME
55  2019 Anti-KL-6/MUC1 monoclonal antibody reverses resistance to trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity by capping MUC1. mAb
56  2019 Antibody Therapies for Acute Myeloid Leukemia: Unconjugated, Toxin-Conjugated, Radio-Conjugated and Multivalent Formats. AML, NK
57  2019 Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway. NAb
58  2019 Antibody-dependent cellular cytotoxicity targeting CD4-inducible epitopes predicts mortality in HIV-infected infants. CD4i, MTCT
59  2019 Antibody-Induced Internalization of HIV-1 Env Proteins Limits Surface Expression of the Closed Conformation of Env. bNAbs, Env, nnAbs
60  2019 Antitumor effects of the GM3(Neu5Gc) ganglioside-specific humanized antibody 14F7hT against Cmah-transfected cancer cells. CMAH
61  2019 Arming Tumor-Associated Macrophages to Reverse Epithelial Cancer Progression. NK, TAM
62  2019 Assessment of the Molecular Mechanism of Action of SB3, a Trastuzumab Biosimilar. ADCP, HER, MOA, VEGF
63  2019 Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models. RM
64  2019 Brief Report: Decreased JC Virus-Specific Antibody-Dependent Cellular Cytotoxicity in HIV-Seropositive PML Survivors. FcR, JCV, PML, PML P, PML-S
65  2019 Canine non-B, non-T NK lymphocytes have a potential antibody-dependent cellular cytotoxicity function against antibody-coated tumor cells. EGFR, HER2, NK
66  2019 CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab. CR, CRC, CRC, EGFR, NK
67  2019 CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy. BsAb, CD24, HCC, hMICA, IFN-gamma, MICA, NK, NKG2D, SDS-PAGE, SPR, TNF-alpha, WB
68  2019 CD4 Incorporation into HIV-1 Viral Particles Exposes Envelope Epitopes Recognized by CD4-Induced Antibodies. Env
69  2019 CD4- and Time-Dependent Susceptibility of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity. CD4, CD4, CD4i, Env
70  2019 Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol. EGFR, Ig, mCRC
71  2019 Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. CRT, HNSCC, HPV, LA, R/M, RT
72  2019 Characterization of zolbetuximab in pancreatic cancer models. CDC, CLDN18.2, PC
73  2019 Chronic HIV-1 Infection Alters the Cellular Distribution of FcgammaRIIIa and the Functional Consequence of the FcgammaRIIIa-F158V Variant. FcgammaRs
74  2019 Coadministration of CH31 Broadly Neutralizing Antibody Does Not Affect Development of Vaccine-Induced Anti-HIV-1 Envelope Antibody Responses in Infant Rhesus Macaques. bNAb, CD4bs, MTCT, MVA
75  2019 Combination Therapy for Treating Advanced Drug-Resistant Acute Lymphoblastic Leukemia. ALL, NK, TGF-beta
76  2019 Common antibody dependent cell mediated cytotoxicity (ADCC) antibody epitopes of HIV-1 CRF01_AE Env and Gag in early HIV-1 infected individuals. ---
77  2019 Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity. CDC
78  2019 Contributions of natural killer cells to the immune response against Plasmodium. NK
79  2019 Control of therapeutic IgG antibodies galactosylation during cultivation process and its impact on IgG1/FcgammaR interaction and ADCC activity. mAbs
80  2019 Correction to: Immunotherapy Utilizing the Combination of Natural Killer- and Antibody Dependent Cellular Cytotoxicity (ADCC)-Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition. ---
81  2019 Cross-Reactive Antibodies With the Capacity to Mediate HIV-1 Envelope Glycoprotein-Targeted Antibody-Dependent Cellular Cytotoxicity Identified in HIV-2-Infected Individuals. Env, HIV-1, HIV-2
82  2019 Cross-reactive antibody-dependent cellular cytotoxicity antibodies are increased by recent infection in a household study of influenza transmission. ---
83  2019 Customized protein glycosylation to improve biopharmaceutical function and targeting. ---
84  2019 CXCR6+ NK Cells in Human Fetal Liver and Spleen Possess Unique Phenotypic and Functional Capabilities. NK, PB
85  2019 Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2Cnull Human Immunodeficiency Virus-Infected Individuals. HCMV, HIV, HLA, NK, PLZF
86  2019 Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells. ---
87  2019 Daratumumab-225Actinium conjugate demonstrates greatly enhanced antitumor activity against experimental multiple myeloma tumors. CDC, MM, SCID
88  2019 Deciphering Fc-mediated Antiviral Antibody Functions in Animal Models. Abs, Ags
89  2019 Deficient IL-2 Produced by Activated CD56+ T Cells Contributes to Impaired NK Cell-Mediated ADCC Function in Chronic HIV-1 Infection. HIV-1, NK
90  2019 Demonstration of functional similarity of a biosimilar adalimumab SB5 to Humira. CDC, EC
91  2019 Depletion of activated macrophages with a folate receptor-beta-specific antibody improves symptoms in mouse models of rheumatoid arthritis. FRbeta
92  2019 Depletion of the transcriptional coactivators CREB-binding protein or EP300 downregulates CD20 in diffuse large B-cell lymphoma cells and impairs the cytotoxic effects of anti-CD20 antibodies. CBP, DLBCL
93  2019 Development of a kinetic antibody-dependent cellular cytotoxicity assay. mAb, MOA
94  2019 Development of a novel fully-human anti-CD123 antibody to target acute myeloid leukemia. ---
95  2019 Development of a Novel Inhibitory Chimeric Anti-HER2 Monoclonal Antibody. ---
96  2019 Development of a simple new flow cytometric antibody-dependent cellular cytotoxicity (ADCC) assay with excellent sensitivity. FcRgamma, mAbs
97  2019 Development of a universal influenza vaccine using hemagglutinin stem protein produced from Pichia pastoris. HA
98  2019 Development of Human Monoclonal Antibody for Claudin-3 Overexpressing Carcinoma Targeting. CAR, CLDN3
99  2019 Differences in the Binding Affinity of an HIV-1 V2 Apex-Specific Antibody for the SIVsmm/mac Envelope Glycoprotein Uncouple Antibody-Dependent Cellular Cytotoxicity from Neutralization. HIV-1
100  2019 Different mechanisms of the protection against influenza A infection mediated by broadly reactive HA2-specific antibodies. ADP, CDC, HA, IAVs